420EGP
- Active ingredient
- molnupiravir
- Strength
- 200 mg
- Form
- capsule
- Manufacturer
- european egyptian pharm. ind.
- Route
- oral.solid
Uses
Antiviral used for treatment of mild-to-moderate COVID-19 in eligible adults at risk of progression to severe disease.
Do not use if
No formal contraindications have been established based on available data, but hypersensitivity should be considered.
Side effects
Common adverse effects include diarrhea, nausea, dizziness, and headache.
Warnings
Use according to current treatment recommendations. Pregnancy-related precautions may apply.
How it works
A prodrug that is converted to a nucleoside analogue, introducing errors into viral RNA replication.
Storage
Store at 20–25°C.